Funding news
Veirulence Ltd logo

Veirulence Ltd Secures $2 Million in Seed Funding for Groundbreaking Anti-Resistance Bacterial Treatment Innovation

Recently funded · $2.0M SeedBiotechnology Research

Get the full Veirulence Ltd company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Veirulence Ltd, a pioneering biotechnology company dedicated to combating antimicrobial resistance (AMR), has successfully raised $2,000,000 in a recent funding round. This critical investment underscores the urgency of addressing the escalating global health crisis posed by resistant bacteria, particularly in light of the World Health Organization's identification of Pseudomonas aeruginosa as a priority pathogen due to its association with severe hospital-acquired infections. Veirulence's innovative approach focuses on the virulence factors that enable bacteria to thrive and spread disease. Their groundbreaking small molecule specifically targets swarming—a pivotal virulence factor of P. aeruginosa—effectively preventing the pathogen from establishing infections while also enhancing the efficacy of existing antibiotics when used in tandem. The funds raised will be directed towards crucial research and development efforts to bring this novel treatment closer to clinical application, addressing the significant unmet medical needs in bacterial infection management. With rising rates of antibiotic resistance, Veirulence is poised to make a substantial impact on public health by not only halting infections but also improving patient outcomes in acute infection scenarios. The support from investors highlights a growing recognition of the urgent need for innovative solutions in the fight against AMR, and Veirulence Ltd is committed to leading the charge in developing cutting-edge therapies that safeguard global health.

Other recently funded companies

View all

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Parcel Health logo

Parcel Health

United States

$1.2M
2
Envoke logo

Envoke

Canada

$1.6M
3
H2CHP Limited logo

H2CHP Limited

United Kingdom

$1.5M
4
Synthetic logo

Synthetic

Brazil

$10.0M
5
harva. (formerly Supply Pay) logo

harva. (formerly Supply Pay)

United States

$113.0M